VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GLPG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GLPGGalapagos N.V.
$27.98$1.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGLPGCash Flow

Galapagos N.V. (GLPG) Cash Flow Statement

22Y historyFree accessUpdated daily

Liquidity remains under severe pressure as evidenced by a volatile OCF/NI ratio of -5.71 in 2026Q1, highlighting the firm's inability to generate consistent cash from core operations.

GLPG Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04
Cash from Operations-295.81M-189.23M-320.03M-405.97M-500.54M-503.83M-427.34M3.6B-142.47M-147.03M239.4M-114.59M-75.56M522K64.1M-11.99M-18.57M6.3M-8.21M371K-9.31M-3.89M-2.71M
Operating CF Margin %--17.01%-116.1%-169.35%-207.48%-103.91%-89.39%430.82%-49.32%-115.69%184.84%-289.64%-108.92%0.38%47.04%-12.51%-15.17%6.77%-10.66%0.56%-26.48%-34.58%-34.85%
Operating CF Growth %-135.49%40.87%21.17%18.89%0.65%-17.9%-111.88%2624.74%3.1%-161.42%308.92%-51.66%-14574.14%-99.19%634.6%35.44%-394.67%176.78%-2312.67%103.98%-139.52%-43.43%-
Net Income488.78M320.9M74.08M211.7M-217.99M-103.23M-305.44M166.42M-29.26M-115.7M54.01M-118.41M33.21M-11.02M-6.61M-32.94M1.03M1.66M-15.21M-21.87M-11.81M-6.65M-3.61M
Depreciation & Amortization-36.52M035.4M43.64M65.57M34.64M18.68M12.1M5.08M4.29M4.18M3.4M4.65M8.15M9.01M12.1M11.63M6.96M7.37M8.35M4.73M1.31M1M
Stock-Based Compensation-12.66M0056.72M88.51M70.73M79.96M026.76M16.54M11.03M5.04M2.95M2.74M2.09M2.04M2.42M2.64M1.33M1.08M703K00
Deferred Taxes00-1.71M11.69M2.84M2.42M2.12M050K198K235K-1.22M2.34M-2.95M1.71M-2.2M-224K1.35M6.52M-82K-4.5M00
Other Non-Cash Items184.56M375.54M-362.76M-37.28M-60M-78M131.22M265.57M-11.71M26.22M-65.27M30.69M-68.69M154K-2K297K-4.74M-1.39M367K3.37M-2.56M-546K-64K
Working Capital Changes-919.99M-885.68M-65.04M-692.43M-379.47M-430.38M-353.88M3.15B-133.39M-78.56M235.21M-34.09M-50.02M3.44M57.91M8.71M-28.69M-4.92M-8.58M9.51M4.13M1.99M-41K
Change in Receivables-44.84M0-31.05M-39.11M68.98M79.86M-177.16M-75.28M-76K-27.66M-12.98M-7.22M-10.11M1.07M-16.88M00000000
Change in Inventory-17.55M023.04M-24.08M-34.59M-21.17M-100K22.38K3K22K25K-44K-32K-39K291K942K344K1.26M502K-1.45M293K943K51K
Change in Payables000000089.47M20M14.77M2.1M-26.73M02.34M000000000
Cash from Investing258.91M219.35M220.6M71.19M-1.25B541.24M757.29M-4.22B-15.91M-549K-7.29M-4.3M120.61M-8.96M-6.44M2.92M-20.18M-4.74M-9.86M-5.96M-2.47M-3.92M-148K
Capital Expenditures-7.13M0-16.72M-18.71M-27.39M-54.2M-42.52M-51.13M-13.72M-7.44M-4.79M-6.67M-2.8M-7.87M-6.84M-5.83M-4.25M-5.19M-5.7M-6.04M-4.27M-1.11M-148K
CapEx % of Revenue0.68%1.18%6.07%7.8%11.35%11.18%8.89%6.12%4.75%5.85%3.7%16.85%4.04%5.72%5.02%6.08%3.47%5.57%7.41%9.17%12.14%9.88%1.9%
Acquisitions-19.85M00-7M-115.27M28.7M003.33M7K0110K130.79M-1.15M08.71M-15.96M0-857K01.8M-2.81M0
Investments-----------------------
Other Investing150.71M219.35M237.32M16.62M-15.82M-3.66M-45.24M0-3.32M6.52M253K2.37M-7.38M65K399K44K35K443K-3.3M80K000
Cash from Financing-2.77M-3.14M-4.92M-5M-1.49M-3.88M22.04M1.5B287.88M353.36M396M271.37M4.21M55.82M4.03M633K31.16M18.52M-3.92M3.4M39.77M21.16M96K
Debt Issued (Net)-2.37M0-4.92M-6.77M-8.18M-7.19M-6.25M-5.7M-5K-65K-49K-43K-216K-308K-477K-343K-255K-497K-5.08M-2.51M-1.55M-351K-106K
Equity Issued (Net)00000001.5B296.19M363.92M392.12M278.7M054.8M2.74M553K000040.95M21.14M0
Dividends Paid00000000000000000000000
Share Repurchases00000000000000000000000
Other Financing-405.35K-3.14M01.77M6.7M3.31M28.29M0-8.31M-10.5M3.92M-7.29M4.43M00423K31.41M18.65M1.16M5.91M0368K202K
Net Change in Cash-41.3M-5.06M-102.57M-341.31M-1.73B90.3M281.45M382.13M139.59M177.97M632.93M152.6M49.54M46.83M62.09M-7.84M-6.99M20.07M-21.98M-2.22M27.9M13.34M-2.76M
Free Cash Flow-304.55M-202.4M-402.14M-425.24M-537.49M-561.71M-518.65M3.57B-156.18M-154.47M234.61M-121.25M-78.36M-7.35M57.27M-17.82M-22.83M1.12M-13.91M-5.67M-13.58M-5M-2.86M
FCF Margin %-29.18%-18.2%-145.89%-177.39%-222.8%-115.85%-108.49%427.82%-54.07%-121.54%181.14%-306.49%-112.96%-5.34%42.03%-18.59%-18.65%1.2%-18.07%-8.61%-38.62%-44.47%-36.75%
FCF Growth %-19.66%49.67%5.43%20.88%4.31%-8.3%-114.52%2386.96%-1.11%-165.84%293.49%-54.74%-965.96%-112.84%421.3%21.91%-2143.51%108.03%-145.17%58.21%-171.63%-74.88%-
FCF per Share-4.62-3.07-6.08-6.45-8.18-8.58-7.9762.00-3.00-3.125.13-3.40-2.60-0.262.16-0.68-0.940.05-0.66-0.27-1.00-0.56-0.48
FCF Conversion (FCF/Net Income)-0.62x-0.59x-4.32x-1.92x2.30x4.02x1.40x24.00x4.87x1.27x4.43x0.97x-2.27x-0.06x-11.21x0.36x-4.25x2.09x0.56x-0.02x0.82x0.59x0.76x
Interest Paid00689K00000000000000000000
Taxes Paid00000000000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and clinical failure

Persistent Disconnect Between Earnings Reality

As reported in financial statements, the company consistently records negative operating cash flow despite intermittent net income spikes, with the OCF/NI ratio reaching a volatile -5.71 in 2026Q1, suggesting that reported profits are largely accounting artifacts rather than tangible cash generation from core operations.

The persistent gap between net income and operating cash flow indicates that the company's earnings are heavily influenced by non-cash items and milestone-based revenue recognition. Investors should monitor this divergence, as it implies that the underlying business model is not yet capable of self-funding its R&D-heavy cost structure.

Free Cash Flow Margin Erosion

Based on recent quarterly data, FCF margins have remained deeply negative, bottoming out at -173.0% in 2025Q2, which highlights the structural inability of the current commercial and collaboration-based revenue model to cover the substantial cash outflows required for ongoing clinical development and operational overhead.

The consistent negative FCF trajectory suggests that the company is in a state of perpetual cash consumption. This trend warrants further investigation into whether the pivot toward decentralized CAR-T manufacturing will eventually yield the operational efficiencies necessary to stabilize cash burn or if it will simply introduce new, unproven capital requirements.

Working Capital Volatility Signals Instability

According to the provided cash flow data, working capital changes have been highly erratic, including a massive $827.1M outflow in 2025Q4, which suggests significant instability in the timing of milestone payments and the management of liabilities associated with the Gilead collaboration agreement.

These wild swings in working capital appear to be the primary driver of the company's cash flow volatility rather than operational performance. The lack of predictability in these cash movements makes it difficult to forecast the company's runway and suggests that liquidity is highly sensitive to the timing of external partnership events.

Capital Deployment Amidst Cash Scarcity

As indicated by the historical cash flow statements, the company has engaged in sporadic acquisition activity, such as the $31.9M outflow in 2025Q1, despite a deteriorating cash position that may limit its ability to pursue further inorganic growth without dilutive financing or additional partnership capital.

The decision to deploy cash for acquisitions while operating cash flow remains negative suggests a high-risk strategy aimed at buying growth to offset internal pipeline setbacks. Investors should monitor whether these capital allocations provide a clear path to commercialization or if they represent an inefficient use of dwindling liquidity.

GLPG — Frequently Asked Questions

Quick answers to the most common questions about buying GLPG stock.

How much cash does Galapagos N.V. (GLPG) generate from operations?

Galapagos N.V. (GLPG) generated $-189.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Galapagos N.V.'s free cash flow?

Galapagos N.V. (GLPG) reported negative free cash flow of $202.4M in 2025, indicating capital requirements exceeded cash from operations.

What is Galapagos N.V.'s capital expenditure (CapEx)?

Galapagos N.V. (GLPG) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.